Kythera Biophrarma (KYTH) Reports In-Line Q4 EPS

Kythera Biophrarma (NASDAQ: KYTH) reported Q4 EPS of ($1.07), in-line with the analyst estimate of ($1.07).

For earnings history and earnings-related data on Kythera Biophrarma (KYTH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery